Sector
PharmaceuticalsOpen
₹94.1Prev. Close
₹96Turnover(Lac.)
₹6.73Day's High
₹100.8Day's Low
₹94.152 Week's High
₹167.952 Week's Low
₹68.11Book Value
₹18.41Face Value
₹10Mkt Cap (₹ Cr.)
115.78P/E
60.38EPS
1.59Divi. Yield
022 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
6 Sep 2023
12:00 AM
BookCloser
11 Aug 2023
12:00 AM
AGM
Announcement Date: 11 Aug, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 11.49 | 11.63 | 8.5 | 8.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 7.87 | 1.12 | -3.79 | -2.68 |
Net Worth | 19.36 | 12.75 | 4.71 | 5.82 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 2.37 | 7.67 | 5.8 | 5.27 |
yoy growth (%) | -69.1 | 32.33 | 9.92 | -26.96 |
Raw materials | -1.45 | -4.31 | -2.71 | -2.73 |
As % of sales | 61.45 | 56.13 | 46.85 | 51.85 |
Employee costs | -0.44 | -0.51 | -0.88 | -0.79 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -1.25 | -0.47 | -2.47 | -0.96 |
Depreciation | -0.04 | -0.04 | -0.44 | -0.53 |
Tax paid | 0.12 | -1.53 | 0.07 | 0.29 |
Working capital | -1 | -2.28 | 3.43 | -4.45 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -69.1 | 32.33 | 9.92 | -26.96 |
Op profit growth | -183.21 | -148.27 | -277.68 | -252.99 |
EBIT growth | -146.73 | -175.52 | -426.79 | -207.7 |
Net profit growth | -43.51 | -16.46 | 259.74 | -34.27 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 188.71 | 167.61 | 163.03 | 89.52 | 95.31 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 188.71 | 167.61 | 163.03 | 89.52 | 95.31 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.82 | 0.77 | 0.33 | 0.21 | 0.66 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Vindyak B Desai
Director & Chief Executive Off
Prakash M Shah
Managing Director & CFO
Baiju M Shah
Non Executive Director
Ami M Shah
Independent Director
T V Anantharaman
Independent Director
Yogesh Varia
Independent Director
Harish S Panpalia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Parnax Lab Ltd
Summary
Parnax Lab Limited (Formerly Known as Krishna Deep Trade & Investment Ltd ) was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited effective on July 19, 2012. The Company is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities.Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpars prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company now has state-of-the-art accredited manufacturing facilities with high speed packing lines in Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh.Naxpars key strength is manufacturing finished formulations for multinationals in India and abroad and i
Read More
What is the Parnax Lab Ltd share price today?
The Parnax Lab Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹100.8 today.
What is the Market Cap of Parnax Lab Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Parnax Lab Ltd is ₹115.78 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Parnax Lab Ltd?
The PE and PB ratios of Parnax Lab Ltd is 60.38 and 5.21 as of 22 Jul ‘24
What is the 52 Week High and Low of Parnax Lab Ltd?
The 52-week high/low is the highest and lowest price at which a Parnax Lab Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Parnax Lab Ltd is ₹68.11 and ₹167.9 as of 22 Jul ‘24
What is the CAGR of Parnax Lab Ltd?
Parnax Lab Ltd's CAGR for 5 Years at 33.08%, 3 Years at 54.86%, 1 Year at 34.43%, 6 Month at 1.01%, 3 Month at -29.28% and 1 Month at -14.33%.
What is the shareholding pattern of Parnax Lab Ltd?
The shareholding pattern of Parnax Lab Ltd is as follows:
Promoters - 72.30 %
Institutions - 0.00 %
Public - 27.70 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
